RxDoctor Payments Data

Katelyn Carmical, MD

Family Medicine · Monticello, ARNPI 1336534411

Payments from drug & device makers

$2,299in general payments, 2019–2025

Across 151 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$857
  • GSK$233
  • Novo Nordisk$190
  • Pfizer$143
  • Takeda Pharmaceuticals U.S.A., Inc.$114
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$85
  • plus $676 from 19 others

What the payments were for

  • Food & beverage$2,299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,299 in reported general payments places this provider in the 70th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$73,263
Medicare patients
154
Services billed
2,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$8,742
Sucralfate13$815
Bupropion XlBupropion Hcl28$815
Omeprazole31$482
Levothyroxine Sodium55$371
Pantoprazole Sodium27$343
Gabapentin15$322
Hydroxychloroquine Sulfate16$259
Trazodone Hcl21$239
Potassium Chloride18$229
Escitalopram Oxalate14$218
Ropinirole Hcl19$195
Losartan Potassium36$191
Rosuvastatin Calcium14$186
Fluconazole24$186

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$190$8,74211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Monticello

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →